Lipoprotein lipase: A new prognostic factor in chronic lymphocytic leukaemia

Wspolczesna Onkologia

Volumn 16, Issue 6, 2012, Pages 474-479

  Hartman, Mariusz L ^a   Kilianska, Zofia M ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Chronic lymphocytic leukemia; IgV H mutational status; Lipoprotein lipase; Prognostic factors

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; ASPARAGINE; FATTY ACID; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PHOSPHOLIPASE A1; PROTEIN KINASE ZAP 70; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CANCER GROWTH; CANCER PROGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; CELL INTERACTION; CHROMOSOME 8; CHRONIC LYMPHATIC LEUKEMIA; CYTOTOXICITY; DIMERIZATION; ENZYME ACTIVITY; EXON; GENE EXPRESSION; GENE MUTATION; GLYCOSYLATION; GROWTH; HUMAN; LIPID METABOLISM; LYMPHOCYTE; MUSCLE CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN STABILITY; REVIEW; TREATMENT FREE SURVIVAL;

EID: 84872564489     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2012.3247     Document Type: Review

References (47)

1. Foon KA. Chronic lymphoid leukaemias: recent advances in biology and therapy. Stem Cells 1995; 13: 1-21.
2. Robak T. Czynniki prognostyczne w przewlekłej białaczce limfatycznej. Acta Haematol Pol 2003; 34: 395-405. (Pubitemid 38200461)
3. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996. Blood 2008; 111: 5446-56.
4. Montillo M, Hamblin T, Hallek M, Montserrat E, Morra E. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005; 90: 391-9. (Pubitemid 40388989)
5. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-54. (Pubitemid 29430400)
6. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-7. (Pubitemid 29430399)
7. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764-75. (Pubitemid 36514707)
8. Bullrich F, Croce C. Molecular biology of chronic lymphocytic leukemia. In: Chronic lymphocytic leukemias. Cheson B (ed.). Marcel Dekker, Inc., New York 2001; 9-32.
9. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-6. (Pubitemid 32064784)
10. Ghia P, Ferreri AM, Caligaris-Cappio F. Chronic lymphocytic leukemia. Crit Rev Oncol Hematol 2007; 64: 234-46. (Pubitemid 350026781)
11. Oppezzo P, Dighiero G. What do somatic hypermutation teach us about chronic lymphocytic leukemia pathogenesis. Curr Top Microbiol Immunol 2005; 294: 71-89. (Pubitemid 41491251)
12. Herishanu Y, Polliack A. Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options. Transfus Apher Sci 2005; 32: 85-97. (Pubitemid 40292819)
13. Mauerer K, Zahrieh D, Gorgun G, et al. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia. Br J Haematol 2005; 129: 499-510. (Pubitemid 40769899)
14. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated IgVH3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262-4. (Pubitemid 34525519)
15. Pekarsky Y, Zanesi N, Croce CM. Molecular basis of CLL. Semin Cancer Biol 2010; 20: 370-6.
16. Rassenti LZ, Jain S, Keating MJ, et al. Relative value of ZAP-70, CD38 and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 2008; 112: 1923-30.
17. Joks M, Lewandowski K. Prognostyczne znaczenie polimorfizmów genów białek rodziny Bcl-2 u chorych na przewlekła̧ białaczkȩ limfocytowa̧. Wspolczesna Onkol 2008; 12: 162-7.
18. Calin GA, Liu CG, Sevignani C, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004; 101: 11755-60. (Pubitemid 39095368)
19. Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-801. (Pubitemid 41549891)
20. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005; 102: 13944-9. (Pubitemid 41377683)
21. Vasconcelos Y, De Vos J, Vallat L, et al. Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes. Leukemia 2005; 19: 2002-5. (Pubitemid 41554014)
22. Heintel D, Kienle D, Shehata M, et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216-23. (Pubitemid 40946007)
23. Oppezzo P, Vasconcelos Y, Settegrana C, et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005; 106: 650-7. (Pubitemid 40981263)
24. Van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B, Philippé J. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 2007; 53: 204-12. (Pubitemid 46338264)
25. Kaderi MA, Kanduri M, Buhl AM, et al. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 2011; 96: 1153-60.
26. Olivecrona T, Hultin M, Bergö M, Olivecrona G. Lipoprotein lipase: regulation and role in lipoprotein metabolism. Proc Nutr Soc 1997; 56: 723-9. (Pubitemid 127761218)
27. Deeb SS, Peng RL. Structure of the human lipoprotein lipase gene. Biochemistry 1989; 28: 4131-5. (Pubitemid 19141610)
28. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002; 43: 1997-2006. (Pubitemid 35471065)
29. Neuger L, Vilaró S, Lopez-Iglesias C, Gupta J, Olivecrona T, Olivecrona G. Effects of heparin on the uptake of lipoprotein lipase in rat liver. BMC Physiol 2004; 4: 13.
30. Bijvoet SM, Wiebusch H, Ma Y, et al. Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250->Asn; Ser251->Cys) resulting in lipoprotein lipase (LPL) deficiency. Neth J Med 1996; 49: 189-95. (Pubitemid 26375962)
31. van Tilbeurgh H, Roussel A, Lalouel JM, Cambillau C. Lipoprotein lipase. Molecular model based on the pancreatic lipase X-ray structure: consequences for heparin binding and catalysis. J Biol Chem 1994; 269: 4626-33.
32. Zhang L, Lookene A, Wu G, Olivecrona G. Calcium triggers folding of lipoprotein lipase into active dimers. J Biol Chem 2005; 280: 42580-91. (Pubitemid 43049216)
33. Zhang L, Wu G, Tate CG, Lookene A, Olivecrona G. Calreticulin promotes folding/dimerization of human lipoprotein lipase expressed in insect cells (Sf21). J Biol Chem 2003; 278: 29344-51. (Pubitemid 36935851)
34. Beisiegel U, Heeren J. Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors. Proc Nutr Soc 1997; 56: 731-7. (Pubitemid 127761219)
35. Keiper T, Schneider JG, Dugi KA. Novel site in lipoprotein lipase (LPL415-438) essential for substrate interaction and dimer stability. J Lipid Res 2001; 42: 1180-6. (Pubitemid 32744240)
36. Bilban M, Heintel D, Scharl T, et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080-8. (Pubitemid 43797301)
37. Pallasch CP, Schwamb J, Königs S, et al. Targeting lipid metabolism by the lipoprotein inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 2008; 22: 585-92. (Pubitemid 351386729)
38. Nückel H, Hüttmann A, Klein-Hitpass L, Schroers R, Führer A, Sellmann L, Dührsen U, Dürig J. Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2006; 47: 1053-61. (Pubitemid 44102969)
39. van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ, van Lom K, Valk PJ. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006; 91: 56-63. (Pubitemid 43235386)
40. Nikitin EA, Malakho SG, Biderman BV, et al. Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2007; 48: 912-22. (Pubitemid 47161563)
41. Saad AA, El-Shennawy D, El-Hagracy RS, Hamed AI, El-Feky MA, Ismail MA. Prognostic value of lipoprotein lipase expression among Egyptian B-chronic lymphocytic leukemia patients. J Egypt Natl Canc Inst 2008; 20: 323-9.
42. Maloum K, Settegrana C, Chapiro E, et al. IGHV mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. Ann Hematol 2009; 88: 1215-21.
43. Xu W, Li JY, Shen QD, Wu YJ, Yu H, Fan L. Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Lab Hematol 2009; 31: 552-9.
44. Mansouri M, Sevov M, Fahlgren E, et al. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. Leuk Res 2010; 34: 301-6.
45. Kienle D, Benner A, Läufle C, et al. Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia. Haematologica 2010; 95: 102-9.
46. Xu R, Cai J, Xu T, Zhou W, Ying B, Deng K, Zhao S, Li C. Molecular cloning and mapping of a novel ADAM gene (ADAM29) to human chromosome 4. Genomics 1999; 62: 537-9. (Pubitemid 30075187)
47. Caligaris-Cappio F. Role of the microenvironment in chronic lymphocytic leukemia. Br J Haematol 2003; 123: 380-8. (Pubitemid 37363477)